关注
Elizabeth C Hinchy
Elizabeth C Hinchy
Senior Scientist, Astrazeneca, UK
在 astrazeneca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly
EC Hinchy, AV Gruszczyk, R Willows, N Navaratnam, AR Hall, G Bates, ...
Journal of Biological Chemistry 293 (44), 17208-17217, 2018
2602018
Malonylation of GAPDH is an inflammatory signal in macrophages
S Galván-Peña, RG Carroll, C Newman, EC Hinchy, ...
Nature communications 10 (1), 338, 2019
1612019
Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation
JL Martin, ASH Costa, AV Gruszczyk, TE Beach, FM Allen, HA Prag, ...
Nature metabolism 1 (10), 966-974, 2019
1212019
A helminth-derived suppressor of ST2 blocks allergic responses
F Vacca, C Chauche, A Jamwal, EC Hinchy, G Heieis, H Webster, ...
Elife 9, e54017, 2020
452020
Selective disruption of mitochondrial thiol redox state in cells and in vivo
LM Booty, JM Gawel, F Cvetko, ST Caldwell, AR Hall, JF Mulvey, ...
Cell chemical biology 26 (3), 449-461. e8, 2019
432019
Ventriculo‐arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease
RG Axell, SJ Messer, PA White, C McCabe, A Priest, T Statopoulou, ...
Physiological reports 5 (7), e13227, 2017
432017
Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis
S Antonucci, JF Mulvey, N Burger, M Di Sante, AR Hall, EC Hinchy, ...
Free Radical Biology and Medicine 134, 678-687, 2019
412019
Click-PEGylation–a mobility shift approach to assess the redox state of cysteines in candidate proteins
LAG van Leeuwen, EC Hinchy, MP Murphy, EL Robb, HM Cochemé
Free Radical Biology and Medicine 108, 374-382, 2017
392017
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
E England, DG Rees, IC Scott, S Carmen, DTY Chan, ...
Scientific Reports 13 (1), 9825, 2023
282023
APOPT 1/COA 8 assists COX assembly and is oppositely regulated by UPS and ROS
A Signes, R Cerutti, AS Dickson, C Benincá, EC Hinchy, D Ghezzi, ...
EMBO molecular medicine 11 (1), e9582, 2019
212019
Tozorakimab: a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
IC Scott, E England, DG Rees, T Erngren, CC Huntington, KF Houslay, ...
European Respiratory Journal 60 (suppl 66), 2022
82022
Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
E England, DG Rees, IC Scott, S Carmen, DTY Chan, ...
bioRxiv, 2023.02. 28.527262, 2023
22023
Distinct Pharmacological Profiles of IL-33 Antibodies
S Cohen, S Strickson, IC Scott, A Collinson, G Rees, CC Huntington, ...
B32. BIOMARKERS AND TRANSLATIONAL STUDIES IN COPD AND CHRONIC AIRWAYS …, 2024
2024
Succinate accumulation during organ storage drives ischemia-reperfusion injury upon transplantation
JL Martin, ASH Costa, A Gruszczyk, T Beach, F Allen, H Prag, EC Hinchy, ...
University of Glasgow, 2018
2018
SUCCINATE ACCUMULATION IS THE KEY METABOLOMIC SIGNATURE AND THERAPEUTIC TARGET FOR TRANSPLANT ISCHAEMIA-REPERFUSION INJURY IN MOUSE, PIG AND MAN
J Martin, ASH Costa, A Gruszczyk, M Hamad, F Allen, EC Hinchy, ...
BRITISH JOURNAL OF SURGERY 105, 7-7, 2018
2018
How cellular ATP/ADP ratios and reactive oxygen species affect AMPK signalling
E Hinchy
2017
Mitochondrial Hydrogen Peroxide as a Redox Signal
EC Hinchy, MP Murphy, MCM Vissers, MB Hampton, AJ Kettle
Hydrogen Peroxide Metabolism in Health and Disease, 149-160, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–17